You just read:

Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage® System One™ is Associated with Lower Risk of Mortality and Higher Survival Estimates Compared to Conventional Thrice-Weekly Dialysis

News provided by

NxStage Medical, Inc.

Apr 28, 2011, 08:00 ET